Reduced PD-1 expression on circulating follicular and conventional FOXP3<sup>+</sup> Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children

Melanoma and Skin CancerT Cells

Decline of PD-1 positive circulating T regulatory cells predicting more favorable clinical outcome of melanoma patients under immune checkpoint blockade

Br J Dermatol.

Gambichler T, Schröter U, Höxtermann S, Susok L, Stockfleth E, Becker JC

doi: 10.1111/bjd.18379.

Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease at Type 1 Diabetes Diagnosis

J Clin Endocrinol Metab.

Jonsdottir B, Larsson C, Carlsson A, Forsander G, Ivarsson SA, Lernmark Å, Ludvigsson J, Marcus C, Samuelsson U, Örtqvist E, Larsson HE; Better Diabetes Diagnosis Study Group

doi: 10.1210/jc.2016-2335.

T Cells

A Prevalent CXCR3+ Phenotype of Circulating Follicular Helper T Cells Indicates Humoral Dysregulation in Children with Down Syndrome

J Clin Immunol.

Ottaviano G, Gerosa J, Santini M, De Leo P, Vecchione A, Jofra T, Trimarchi C, De Pellegrin M, Agosti M, Aiuti A, Marinoni M, Cicalese MP, Fousteri G

doi: 10.1007/s10875-020-00755-0.

Abatacept attenuates T follicular helper-cell-dependent B-cell hyperactivity in primary Sjögren's syndrome

Arthritis Rheumatol.

Verstappen GM, Meiners PM, Corneth OBJ, Visser A, Arends S1, Abdulahad WH, Hendriks RW, Vissink A, Kroese FGM, Bootsma H

doi: 10.1002/art.40165.

Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules

J Am Acad Dermatol.

Ben-Shachar S, Dubov T, Toledano-Alhadef H, Mashiah J, Sprecher E, Constantini S, Leshno M, Messiaen LM

doi: 10.1016/j.jaad.2017.02.027.

COMMENTED

Immunotherapy

Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes

★ 0 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

J Autoimmun

Lombardi A, Concepcion E, Hou H, Arib H, Mezei M, Osman R, Tomer Y

doi: 10.1016/j.jaut.2020.102543

T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival

J Immunol.

A Verghese D, Demir M, Chun N, Fribourg M, Cravedi P, Llaudo I, Woodruff TM, Yadav P, Lira SA, Medof ME, Heeger PS

doi: 10.4049/jimmunol.1701638.

Allergic DiseasesT Cells

Associations of Th2, Th17, Treg cells and IgA+ memory B cells with atopic disease in children: the Generation R Study

Allergy.

Looman KIM, van Meel ER, Grosserichter-Wagener C, Vissers FJM, Klingenberg JH, De Jong NW, de Jongste JC, Pasmans SGMA, Duijts L, van Zelm MC, Moll HA

doi: 10.1111/all.14010.

COMMENTED

Further Publications Dermatology

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

★ 2 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Lancet

Rosenstock J, Wysham C, Frías JP, Kaneko S, Lee CJ, Fernández Landó L, Mao H, Cui X, Karanikas CA, Thieu VT

doi: 10.1016/S0140-6736(21)01324-6

Dermatology · Immunology · Rheumatology

Reduced PD-1 expression on circulating follicular and conventional FOXP3⁺ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children

Related content